Detection of metastatic cervical lymph nodes in recurrent papillary thyroid carcinoma: Computed tomography versus positron emission tomography-computed tomography

Journal of Computer Assisted Tomography

Volumn 33, Issue 5, 2009, Pages 805-810

  Lee, Dong Hoon ^a   Kang, Won Jun ^a   Seo, Hyung Suk ^a,b   Kim, Eunhee ^a   Kim, Ji Hoon ^a   Son, Kyu Ri ^a   Na, Dong Gyu ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

CT; Lymph node metastasis; Papillary thyroid cancer; PET CT

Indexed keywords

BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; ELECTRONS; POSITRON EMISSION TOMOGRAPHY;

CECT; CERVICAL LYMPH NODES; COMPUTED TOMOGRAPHY IMAGES; CONTRAST-ENHANCED; CONTRAST-ENHANCED CT; LYMPH NODE METASTASIS; METASTATIC LYMPH NODES; PAPILLARY THYROID CANCER; PAPILLARY THYROID CARCINOMATA; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES;

POSITRONS;

FLUORODEOXYGLUCOSE F 18; IOPROMIDE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; NECK; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THYROID PAPILLARY CARCINOMA;

EID: 70349757173     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31818fb3f1     Document Type: Article

References (36)

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338:297-306.
2. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid. 1999;9:421-427. (Pubitemid 29244917)
3. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-424. (Pubitemid 20261828)
4. Schlumberger MJ, Torlontano M. Papillary and follicular thyroid carcinoma. Baillieres Clin Endocrinol Metab. 2000;14:610-613.
5. Hay I, Bergstralh E, Goellner J, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;14:1050-1058.
6. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447-1463.
7. National Comprehensive Cancer Network (NCCN). Thyroid carcinoma clinical practice guidelines in oncology, version 2: oncology. Available at: http://www.nccn.org. Accessed 2007.
8. American Thyroid Association Guideline Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:1-33.
9. Branstetter BF 4th, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology. 2005;235:580-586.
10. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-d-glucose and MR imaging correlation. Radiology. 1993;186:27-35. (Pubitemid 23005462)
11. Myers LL, Wax MK, Nabi H, et al. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope. 1998;108:232-236. (Pubitemid 28128213)
12. Yoon YC, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology. 2003;227:764-770.
13. Schoder H, Yeung HW, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65-72. (Pubitemid 38375411)
14. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004;22:4357-4368. (Pubitemid 41185156)
15. Bui CD, Ching AS, Carlos RC, et al. Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-d-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck. Invest Radiol. 2003;38:593-601. (Pubitemid 37046505)
16. Yeo JS, Chung JK, So Y, et al. F-18-Fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes. Head Neck. 2001;23:94-103. (Pubitemid 32060661)
17. Chung JK, So Y, Lee JS, et al. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med. 1999;40:986-992. (Pubitemid 29269219)
18. Frilling A, Tecklenborg K, Gorges R, et al. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well differentiated thyroid carcinoma. Ann Surg. 2001;34:804-811.
19. Menzel C, Zaplatnikov K, Diehl M, et al. The influence of thyroglobulin on functional imaging in differentiated thyroid cancer. Nucl Med Commun. 2004;25:239-243. (Pubitemid 38393514)
20. Dietlein M, Scheidhauer K, Voth E, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med. 1997;24:1342-1348. (Pubitemid 27507513)
21. Nahas Z, Goldenberg D, Fakhry C, et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope. 2005;115:237-243. (Pubitemid 40216695)
22. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002:77-87.
23. Som PM, Brandwein M, Lidov M, et al. The varied presentations of papillary thyroid carcinoma cervical nodal disease: CT and MR findings. AJNR Am J Neuroradiol. 1994;15:1123-1128. (Pubitemid 24184372)
24. van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990;177:379-384.
25. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol. 1992;158:961-969.
26. Mancuso AA, Harnsberger HR, Muraki AS, et al. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part II: pathology. Radiology. 1983;148:715-723.
27. 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT. Clin Endocrinol. 2006;65:402-407.
28. Feine U, Lietzenmayer R, Hanke JP, et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med. 1996;37:1468-1472. (Pubitemid 26321624)
29. Ferris RL, Branstetter BF, Nayak JV. Diagnostic utility of positron emission tomography-computed tomography for predicting malignancy in cystic neck masses in adults. Laryngoscope. 2005;115:1979-1982.
30. Frasoldati A, Pesenti M, Gallo M, et al. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer. 2003;97:90-96. (Pubitemid 36033867)
31. Pacini F, Molinaro E, Castagna MG, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:3668-3673. (Pubitemid 37034512)
32. Torlontano M, Attard M, Crocetti U, et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab. 2004;89:3402-3407. (Pubitemid 38951911)
33. Hooft L, Hoekstra OS, Deville W, et al. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:3779-3786. (Pubitemid 32755976)
34. Pfannenberg AC, Aschoff P, Brechtel K, et al. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. Br J Radiol. 2007;80:437-445. (Pubitemid 47322230)
35. Nygaard B, Nygaard T, Jensen LI, et al. Iohexol: effects on uptake of radioactive iodine in the thyroid and on thyroid function. Acad Radiol. 1998;5:409-414. (Pubitemid 28279995)
36. European Society of Urogenital Radiology. ESUR guidelines on contrast media, version 6.0. Available at http://www.esur.org/ESUR-Guidelines-NEW.6.0. html. accessed 2008.